Compare UnitedHealth Group Inc (UNH) vs Wells Fargo & Co (WFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
UnitedHealth Group Inc vs Wells Fargo & Co — how do they compare? UnitedHealth Group Inc trades at $394.3 (market cap $352.81B), while Wells Fargo & Co trades at $90.1 (market cap $271.16B). The key difference: UnitedHealth Group Inc is the larger of the two by market cap, and UnitedHealth Group Inc pays the higher dividend (2.36%). Which is the better fit depends on your goals.
| UNH | WFC | |
|---|---|---|
Market Cap | $352.81B | $271.16B |
Sector | Health | Financials |
52-Week High | $436.35 | $96.40 |
52-Week Low | $259.02 | $73.42 |
Enterprise Value | $394.67B | — |
Dividend Yield | 2.36% | 2.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
UnitedHealth Group (UNH) trades at $393.06, down 1.03% on the day, with a bullish technical signal from moving averages and strong analyst support. The company reported revenue of $447.57B in 2025, with net income of $12.06B, and has beaten EPS estimates in recent quarters. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns via dividends and buybacks.
The outlook for UNH is positive, driven by aging demographics, Medicare growth, and operational efficiencies, though risks include regulatory scrutiny and margin pressures. With 82.7% of analysts rating it a buy and a consensus price target of $475.47, the stock presents a compelling opportunity for long-term investors seeking exposure to healthcare stability and dividend growth.
Wells Fargo (WFC) trades at $87.98, down 2.21% on the day, amid mixed earnings performance but strong profitability trends. The stock shows a bullish technical signal with support near $87 and resistance at $89, while fundamentals reveal a P/E of 12.78 and net income margin of 25.97% for 2025. Recent news highlights CEO Charlie Scharf's focus on dealmaking and a push to expand wealth management, with institutional buying activity noted in August 2026 filings.
Outlook remains cautiously optimistic with a consensus price target of $97.64, implying 11% upside, supported by improved return on tangible common equity and dividend payments. Risks include volatile cash flows, regulatory scrutiny, and interest rate sensitivity. Analyst consensus is balanced with 45% buy ratings, but recent earnings misses warrant monitoring execution against guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →About Wells Fargo & Co
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →
